Creatine for Women in Midlife: What It Does, and What It Does Not
In postmenopausal women, creatine monohydrate at 5 g a day paired with resistance training produces small but real gains: 0.37 kg of lean mass (95% CI 0.05 to 0.69) and 7.5 kg on leg press one-rep max (95% CI 2.2 to 12.8), pooled across 7 randomized trials in 608 women. Bone density was unchanged overall, so the bone benefit it is most often marketed on is the one claim the randomized trials do not support. Trials using 3 g a day or less without resistance training showed no measurable effect, which makes the training half of this non negotiable.
Take 5 g of creatine monohydrate a day 5 g of plain creatine monohydrate, once a day, every day including rest days. Timing did not distinguish the trials; consistency did. The pooled benefit appeared at 5 g a day or more, while trials at 3 g a day or less without resistance training showed no measurable effect.
5 g a day is the dose the trials that worked actually used, and it is the dose the null trials undershot.
Pair it with resistance training, not instead of it Every pooled benefit in the review came from trials that combined creatine with a resistance-training program. Creatine at a low dose without training is where the null results sit. If you are not training, the supplement is not the lever.
This is the single most misread part of the evidence: the trials tested creatine plus training against training, not creatine against nothing.
Give it at least 12 weeks before judging it The pooled trials ran 12 to 104 weeks, with a median of 38 weeks. Nothing in this evidence base supports judging the result after a few weeks.
The endpoints that moved (lean mass, one-rep max) are slow-moving, and the shortest trial included was 12 weeks.
Do not buy it for your bones Across the pooled randomized trials, bone density was unchanged overall, and the authors' own conclusion is that effects on bone density remain unclear. A widely cited 2021 narrative review does report favourable bone effects when creatine is combined with resistance training, so the field genuinely disagrees. When a narrative review and a meta-analysis of randomized trials conflict, the pooled trials carry more weight.
Bone is the claim creatine is most often sold on to women in this age group, and it is the claim with the weakest support. Publishing the conflict is more useful than smoothing it.
Treat the memory finding as suggestive, and note who it was found in A meta-analysis of randomized trials in healthy people found a small overall improvement in memory measures (SMD 0.29, 95% CI 0.04 to 0.53). The effect was concentrated in adults aged 66 to 76 (SMD 0.88, 95% CI 0.22 to 1.55) and was absent in people aged 11 to 31 (SMD 0.03, 95% CI -0.14 to 0.20).
A real but small signal in older adults, and no signal at all in young adults. Both halves have to travel together or the finding gets oversold.
Read the mood trial as one small add-on study, nothing more In a single 8-week randomized double-blind trial, 52 women with major depressive disorder took either creatine 5 g a day or placebo in addition to a prescribed SSRI. The creatine group improved more on the Hamilton Depression Rating Scale, with the difference visible as early as week 2.
One trial in 52 people, added on top of prescription treatment. It is not evidence that creatine treats depression, and it is never a reason to delay or replace care.
Menopause brings accelerated loss of muscle mass and strength.
View sources
Creatine monohydrate for lean mass, strength, and bone density in postmenopausal women: a systematic review and meta-analysis (Naddafha et al., JISSN, 2026)
Effects of creatine supplementation on memory in healthy individuals: a systematic review and meta-analysis of randomized controlled trials (Prokopidis et al., Nutrition Reviews, 2023)
Oral creatine monohydrate augmentation of an SSRI in women with major depressive disorder (Lyoo et al., American Journal of Psychiatry, 2012)
Creatine Supplementation in Women's Health: A Lifespan Perspective (Smith-Ryan et al., Nutrients, 2021)
Not medical advice. This page is for education only and is not a substitute for professional medical care. Consult a qualified clinician before changing your health routine.
Editorial disclosure. This protocol is written and fact-checked by the YourProtocol editorial team directly from the primary sources cited below; it is not written or reviewed by any outside expert.
Is this for you
- Women in perimenopause, menopause or after it who are already strength training and want to know if creatine adds anything
- Anyone who has seen creatine marketed to midlife women for bone density and wants the trial evidence on that specific claim
- Readers who want the honest size of the effect before spending money on it
Cautions
- Educational only, not medical advice; talk to your doctor before starting any supplement, particularly if you have kidney disease or take regular medication
- The effect sizes here are small and were measured alongside resistance training, not in place of it
- Bone density was unchanged in the pooled randomized trials; do not take this for bone protection
- The mood finding is a single 52-person trial of creatine added to prescribed treatment, and is not a treatment for depression
- Worth knowing when you read the meta-analysis: one of its senior authors chairs a creatine scientific advisory board supported by a creatine manufacturer, and the publishing society receives funding from creatine companies, which the paper discloses itself
- Trials pooled here ran 12 to 104 weeks; there is no long-term data beyond that window in this population
Common questions
Some links earn us a commission. It never affects our picks or grades. See our affiliate disclosure.